Bayer Partners with Atara Therapeutics for Mesothelin-directed CAR-T Therapies

By Shikha Kashyap & Michelle Liu

Pharma Deals Review: Vol 2021 Issue 2 (Table of Contents)

Published: 4 Feb-2021

DOI: 10.3833/pdr.v2021.i2.2589     ISSN: 1756-7874

Section: Research & Development



In its latest cell and gene therapy effort, Bayer has agreed to partner with Atara Therapeutics for mesothelin-targeting chimeric antigen receptor T-cell therapies for the treatment of solid tumours...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details